Home › Molecular Devices Partners With Roche To Develop Custom Ruthenium Nano-TRF Detection Platform
 

Keywords :   


Molecular Devices Partners With Roche To Develop Custom Ruthenium Nano-TRF Detection Platform

2014-11-05 07:07:55| drugdiscoveryonline Home Page

The custom technologies arm of Molecular Devices, a leader in bioanalytical systems for drug discovery, life science research, and bioassay development, has partnered with the Discovery Technologies team at the Roche Innovation Center Basel of Pharma Research and Early Development (pRED) to develop a high-throughput detection system for drug discovery screens employing Roche's proprietary Ruthenium-based nanosecond time resolved fluorescence (Nano-TRF®) assays

Tags: partners develop custom devices

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
13.05Melinda French Gates to quit Gates Foundation
13.05BASF in South Carolina Joins with Make-A-Wish
13.05PCMC addresses latest printing trends at \'Power Packs Live\'
13.05More than 50 sessions scheduled for drupa cube
13.05IDENTCO highlights automation and PCB labeling at PCB East
13.05Piracy on social media and messaging apps grows in Asia Pacific
13.05Anoki launches AI-powered experience on Google TV
13.05INDA, AFS Partner on FiltXPO 2025 Conference Program
More »